Respiratory disease in athletes encompasses a range of conditions that can impair lung function and performance, including exercise-induced bronchoconstriction, asthma, allergic rhinitis, and infections. High levels of physical activity and exposure to environmental stressors, such as cold air, pollutants, or chlorine in swimming pools, may trigger or worsen symptoms. Athletes may report shortness of breath during exertion, wheezing, persistent cough, or reduced exercise tolerance. Diagnosis involves detailed history-taking, pulmonary function testing, exercise challenge tests, and assessment of environmental and training factors. Accurate identification is critical to differentiate disease from normal physiological adaptations to high-intensity training.
Management strategies combine medical interventions, lifestyle adjustments, and training modifications. Pharmacologic therapies may include inhaled corticosteroids, bronchodilators, and leukotriene receptor antagonists, depending on the specific condition. Preventive measures, such as pre-exercise warm-up routines, airway humidification, and avoidance of triggers, are equally important. Pulmonary function monitoring and collaboration between sports physicians, pulmonologists, and trainers help optimize performance while minimizing respiratory complications. Education of athletes regarding early symptom recognition, adherence to treatment, and safe training environments is essential. Comprehensive respiratory care enables athletes to maintain peak performance while protecting long-term lung health.
Title : Novel signaling mechanisms and innovative therapeutic strategies of pulmonary hypertension
Yong Xiao Wang, Albany Medical College, United States
Title : Changing population immunity to COVID-19 in the context of infection, vaccination and emerging SARS-CoV-2 variants
Ranjan Ramasamy, ID-FISH Technology, United States
Title : Susceptibility to SARS-CoV-2 infection and nasal air conditioning ability
Ranjan Ramasamy, ID-FISH Technology, United States
Title : Comparative evaluation of DECAF and BAP 65 scores in predicting outcomes of COPD exacerbations among in patients at Vicente Sotto Memorial Medical Center
Allanys Joy Q Pino, Vicente Sotto Memorial Medical Center, Philippines
Title :
Saurabh Chattopadhyay, University of Kentucky College of Medicine, United States
Title : Personalized and precision Medicine (PPM) as a unique healthcare model through biodesign driven and inspired biotech, translational applications and pulmonology related marketing to secure the human healthcare, wellness and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation